Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of ocrelizumab in participants with Relapsing Multiple Sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 4 | Status: RECRUITING